Sestrin2 in atherosclerosis

Clin Chim Acta. 2021 Oct 16:S0009-8981(21)00363-6. doi: 10.1016/j.cca.2021.10.019. Online ahead of print.ABSTRACTAtherosclerosis (AS) is the pathological basis of numerous lethal diseases, such as myocardial infarction, heart failure, and stroke. As we know, almost twenty million people worldwide die of the arterial diseases annually. Sestrin2 is a stress-inducing protein, which serves as a guardian by activating AMPK, inhibiting mTOR, and maintaining redox balance beneath various stress environments. A large number of studies show that Sestrin2 would shield the body from injury by stress. Moreover, it has been demonstrated that Sestrin2 is closely connected with AS. Here, this article reviewed the involvement of Sestrin2 in the pathogenesis of AS from four aspects: cellular mechanism, oxidative stress, inflammation, and lipid metabolism. Current evidence reveals that Sestrin2 is a novel target for the prevention and treatment of AS.PMID:34666031 | DOI:10.1016/j.cca.2021.10.019
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Source Type: research